stock logo
KILITCH-BE
₹441.15
-9.00 (2.00%)

Kilitch Drugs (India) Ltd. (KILITCH-BE) live share price today at NSE / BSE

Overview
Charts
Results
News & Events

Expert Verdict for Kilitch Drugs (India) Ltd. (KILITCH-BE) Share

View details
Today`s low
0.00
Today`s high
0.00
Today`s return
Kilitch Drugs (India) Ltd. (KILITCH-BE) Share Price Today
Performance Of Kilitch Drugs (India) Ltd. (KILITCH-BE) Share Today
Opening Price:0.00
Previous closing Price:450.15
Volume of Kilitch Drugs (India) Ltd. (KILITCH-BE) share:643
Value of Share:441.15
Fundamental of Kilitch Drugs (India) Ltd. (KILITCH-BE) Share Price
Market Capitalisation:778 Cr.
P/E Ratio:29.13
P/B Ratio:3.08
Sector P/E:45.61
EPS (TTM):15.27
Dividend Yield:0.00
14D - RSI:55.84
50 DMA:444.52
200 DMA:358.80

Note: The above data is mentioned as per the Kilitch Drugs (India) Ltd. (KILITCH-BE) share price today.

Kilitch Drugs (India) Ltd. (KILITCH-BE) Share Price Today At NSE

    • Live Kilitch Drugs (India) Ltd. (KILITCH-BE) Share Price NSE India: ₹441.15
    • Previous Closing Price: ₹450.15
    • Open Price: ₹0.00
    • High: ₹441.15
    • Low: ₹441.15

Kilitch Drugs (India) Ltd. (KILITCH-BE) Share Price Today At BSE

  • Live Kilitch Drugs (India) Ltd. (KILITCH-BE) Share Price BSE India: ₹444.95
  • Previous Closing Price: ₹454.00
  • Open Price: ₹444.95
  • High: ₹444.95
  • Low: ₹444.95

Historical Price Of Kilitch Drugs (India) Ltd. (KILITCH-BE) Share

The table below shows the variations in Kilitch Drugs (India) Ltd. (KILITCH-BE) share price from January 2018 to July 2025.

Month & YearPrice (INR)Open Price (INR)High Price (INR)Low Price (INR)Volume (Cr.)Change %
January 201884.1087.2092.7080.003,27,129-3.56
February 2018125.1584.30135.9572.0535,33,45348.46
March 201879.30125.50129.0074.0013,08,645-36.81
April 201886.2582.9098.4578.702,60,8664.04
May 201884.2086.0595.5077.052,44,832-2.15
June 201883.0084.5597.0077.552,82,379-1.83
July 2018101.3084.95107.1080.304,14,93519.25
August 2018137.55102.00162.75101.3015,82,24034.85
September 2018142.90139.70149.90122.005,25,6792.29
October 2018186.70135.95195.00126.2522,02,87637.33
November 2018176.85190.00208.80172.5521,37,759-6.92
December 2018159.60179.75180.00148.007,95,357-11.21
January 2019213.70160.05242.80158.0566,85,30433.52
February 2019184.80217.85217.85178.9514,81,151-15.17
March 2019194.95186.50210.00180.0010,61,3004.53
April 2019187.80195.05219.00185.2511,03,438-3.72
May 2019173.20187.05208.45161.309,88,139-7.4
June 2019146.95174.75178.20142.254,39,900-15.91
July 2019110.05147.00152.15108.503,97,783-25.14
August 2019104.75114.40155.0092.9513,61,975-8.44
September 2019120.95105.30129.65103.502,47,83214.86
October 2019117.00121.00126.10111.301,62,082-3.31
November 2019116.10120.65142.50113.052,89,509-3.77
December 2019127.40114.20141.80113.054,79,39811.56
January 2020120.55129.40133.00116.702,45,810-6.84
February 2020101.20120.55136.4596.805,29,558-16.05
March 202081.8599.30115.4061.003,68,983-17.57
April 2020105.5081.90121.0081.905,13,95328.82
May 202090.45104.00105.5087.251,16,341-13.03
June 202098.7591.55139.0091.0011,01,6387.86
July 202086.0098.0098.0085.001,50,459-12.24
August 202090.2588.90101.6584.402,80,4291.52
September 202081.9589.0095.6078.601,86,501-7.92
October 202089.6580.25107.0080.004,76,12211.71
November 202093.2087.7099.7585.2581,5966.27
December 202096.3593.20100.0090.751,56,2973.38
January 202188.3596.00103.4087.0595,843-7.97
February 202187.8088.3095.0084.701,02,842-0.57
March 202180.2590.0092.9579.052,73,027-10.83
April 2021106.1583.45119.4080.4513,82,80327.2
May 2021163.15109.00185.00105.4514,22,68849.68
June 2021156.15155.50173.25146.103,23,6920.42
July 2021219.65156.00224.80141.108,52,91640.8
August 2021172.70228.90228.90160.853,08,046-24.55
September 2021166.45180.90187.10159.502,13,694-7.99
October 2021154.30169.40183.40150.002,01,898-8.91
November 2021155.90151.20195.00148.052,65,1163.11
December 2021249.55157.95251.00150.3010,39,44457.99
January 2022224.10262.00275.10217.152,55,162-14.47
February 2022169.45228.95233.60161.403,03,342-25.99
March 2022167.35165.10188.10162.601,46,1311.36
April 2022186.75173.70218.95168.051,75,6827.51
May 2022171.05192.70192.70145.001,45,968-11.24
June 2022155.80176.15181.60145.0093,338-11.55
July 2022162.00154.55191.00151.003,48,7674.82
August 2022169.85163.95175.00157.001,61,3583.6
November 2023330.00285.00336.90281.003,76,43215.79
December 2023369.30336.60389.00329.002,78,8779.71
January 2024435.25376.00453.90340.005,68,90915.76
February 2024385.40430.45470.00368.203,10,459-10.47
March 2024388.90390.00400.00321.701,63,894-0.28
April 2024362.70399.00399.00340.001,58,167-9.1
May 2024337.55366.10368.95320.201,33,858-7.8
June 2024334.40346.15363.00315.003,05,993-3.39
July 2024374.15334.40387.00324.407,00,22111.89
August 2024332.80375.00395.00321.003,07,561-11.25
September 2024343.35343.00404.95328.856,26,9150.1
October 2024320.70346.95354.00300.101,52,723-7.57
November 2024317.00333.90358.40300.005,52,960-5.06
December 2024326.20321.00351.05310.952,98,7191.62
January 2025313.80326.20372.000.002,65,717-3.8
February 2025309.00312.20352.00303.301,78,946-1.02
March 2025362.60308.00367.50300.052,03,32317.73
April 2025402.65357.20431.00299.957,98,63912.72
May 2025441.10401.00499.00343.1018,08,06410
June 2025442.05443.00472.00412.052,59,325-0.21
July 2025441.15450.90500.00420.005,35,582-2.16

Shareholding Pattern of Kilitch Drugs (India) Ltd. (KILITCH-BE) Shares In Stock Market

The below depicted shareholding pattern is as per the Kilitch Drugs (India) Ltd. (KILITCH-BE) Industries Ltd. Share Price Market of June 2025.

Promoters69.23%
Foreign Institutions0.00%
Retail and Others30.77%
Other Domestic Institutions0.00%
Mutual Funds0.00%
Kilitch Drugs (India) Ltd. (KILITCH-BE) Share Background
Face Value10.00
ISININE729D01010
Market Lot1.00
InstrumentEQUITY
Should you invest in Kilitch Drugs (India) Ltd. (KILITCH-BE) Industries Limited?
  • Every milestone results from a lot of hard work, effort, and making the correct decisions, but patience is essential.
  • Patience is the key to success in the share market, which is also important in attaining benefits on Kilitch Drugs (India) Ltd. (KILITCH-BE) share price.
  • In terms of investment, the investor’s patience pays off with a high return, which is why long-term investors are the most successful.
  • Kilitch Drugs (India) Ltd. (KILITCH-BE) Industries has produced a great return to the last year and is reaching new milestones daily; it has become the first Indian firm to attain a market capitalisation of 778 Cr.
  • Kilitch-be FAQs

    Is Kilitch Drugs (India) Ltd. a good stock to invest in?

    arrow

    Our expert verdict states that Kilitch Drugs (India) Ltd. is in Buy zone for Short term and is in Buy zone for Long term.

    Should I buy Kilitch Drugs (India) Ltd. share now?

    arrow

    As per our verdict, Kilitch Drugs (India) Ltd. is in the Buy zone for Short term.

    Should I buy Kilitch Drugs (India) Ltd. shares for the long term?

    arrow

    As per our verdict, Kilitch Drugs (India) Ltd. is in Buy zone for Long term.

    What is Kilitch Drugs (India) Ltd. share price today?

    arrow

    The Kilitch Drugs (India) Ltd. share price today is 441.15.

    How to buy Kilitch Drugs (India) Ltd. share?

    arrow

    You can buy Kilitch Drugs (India) Ltd. shares on any demat broker by completing your KYC. Before buying any stock, check BUY/SELL/HOLD insights on the Univest App.

    What is the share price of Kilitch Drugs (India) Ltd.?

    arrow

    The share price of Kilitch Drugs (India) Ltd. is 441.15, please note that the price may vary on a real-time basis.

    What is the PE and PB ratio of Kilitch Drugs (India) Ltd.?

    arrow

    PE ratio of Kilitch Drugs (India) Ltd. is 29.13 and PB ratio of Kilitch Drugs (India) Ltd. is 3.08.

    How’s PE of Kilitch Drugs (India) Ltd. compared to its sector?

    arrow

    PE ratio of Kilitch Drugs (India) Ltd. is 29.13 whereas the sector PE ratio is 45.61.

    What is the market cap of Kilitch Drugs (India) Ltd.?

    arrow

    Kilitch Drugs (India) Ltd.’s market cap is 777.8.

    What are today’s High and Low prices of Kilitch Drugs (India) Ltd. ?

    arrow

    Today’s High of Kilitch Drugs (India) Ltd. is 441.15.
    Today’s Low of Kilitch Drugs (India) Ltd. is 441.15.

    icon

    100% Safe & Secure Platform.

    Univest encrypts all data and transactions to ensure a completely secure experience for our members.

    Copyright

    2025 Univest. All rights reserved. | Designed with ❤️ in India
    About Univest
    About: Univest is a cutting-edge stock market platform designed to help traders and investors maximize their returns with expert-driven advisory services and seamless trading execution. Whether you're a seasoned trader or just starting, Univest simplifies your investment journey with actionable trade recommendations, AI-powered portfolio insights, and a fully integrated brokerage experience. With Univest, you gain access to proven stock market advisory, offering expert trade ideas for stocks, futures, options, and commodities. Our one-click trade execution feature eliminates slippage, ensuring instant execution through our advisory-first brokerage. Smart portfolio management allows you to identify underperforming stocks, optimize your investments, and receive real-time alerts. Additionally, Univest provides seamless investment opportunities beyond stocks, including mutual funds, bonds, fixed deposits, and insurance (coming soon). Join over 40 lakh active investors who trust Univest to make informed and profitable trading decisions. Start investing smarter today! 🚀  
    Attention Investors : To ensure a smooth trading experience and prevent unauthorized transactions, investors must update their mobile number and email ID with their stockbroker or depository participant. As per regulatory requirements, investors are required to pay a stipulated amount as an upfront margin for trading in the Cash/FO segment. We encourage all investors to regularly check their securities in the Consolidated Account Statement (CAS) issued by depository to verify their holdings.Always verify alerts and transaction details received directly from the exchange or NSDL before proceeding with any trades. Please do not make payments through unverified email links, WhatsApp, or SMS. Always trade through a registered stockbroker and verify all details before making financial decisions.
     
    Disclaimer: Investments in the securities market are subject to market risks. Please read all related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. For more disclaimer /disclosure, visit https://univest.in/stock-broker or Univest App.We collect and use your contact information for legitimate business purposes, including providing updates on our products and services. We do not sell or rent your contact information to third parties. By submitting your details, you authorize us to contact you via Call/SMS, even if you are registered under DND. This authorization remains valid for 12 months.For grievances, please contact us at hello@unibrokers.in .
     
    Univest Stock Broking Disclosures
    Univest Stock Broking Private Limited - SEBI Reg. No. INZ000317437 (Stock Broker), NSE TM Code: 90392, BSE TM Code: 6866, MCX TM Code: 57290 and ICCL- Self Clearing Member Code: 6866, SEBI Reg. No. IN-DP-779-2024 (Participant), NSDL DP ID: IN304748.
     Risk Disclosures on Derivatives
    1. 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
    2. On an average, loss makers registered net trading loss close to ₹ 50,000
    3. Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
    4. Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
    Attention Investors: As per NSE circular dated July 6, 2022: https://nsearchives.nseindia.com/content/circulars/INSP52900.pdf, BSE circular dated July 6, 2022: https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20220706-55, MCX circular dated July 11, 2022: https://www.mcxindia.com/docs/default-source/circulars/english/2022/july/circular-418-2022.pdf?sfvrsn=9401991_0, investors are cautioned to abstain them from dealing in any schemes of unauthorised collective investments/portfolio management, indicative/ guaranteed/fixed returns / payments etc. 
    Investors are further cautioned to avoid practices like:
    a. Sharing 
    i) trading credentials – login id and passwords including OTPs.
    ii) trading strategies,
    iii) position details.
    b. Trading in leveraged products /derivatives like Options without proper understanding, which could lead to losses.
    c. Writing/ selling options or trading in option strategies based on tips, without basic knowledge and understanding of the product and its risks.
    d. Dealing in unsolicited tips through platforms like Whatsapp, Telegram, Instagram, YouTube, Facebook, SMS, calls, etc.
    e. Trading / Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers.
     Kindly read the Advisory Guidelines For Investors as prescribed by the Exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client’s assets: https://nsearchives.nseindia.com/content/circulars/INSP49434.pdf
    Kindly, read the advisory as prescribed by the Exchange with reference to their circular: NSE/ISC/51035 dated January 14, 2022 regarding Updation of mandatory KYC fields by March 31, 2022: https://www.nseindia.com/resources/exchange-communication-circulars# 
    Attention Investors: Prevent unauthorised transactions in your Demat account by updating your mobile number with your depository participant. Receive alerts on your registered mobile number for debit and other important transactions in your Demat account directly from NSDL on the same day. Prevent unauthorised transactions in your Trading account by updating your mobile numbers/email addresses with your stock brokers. Receive information on your transactions directly from the Exchange on your mobile/email at the end of the day. Issued in the interest of investors. KYC is a one-time exercise while dealing in securities markets - once KYC is done through a SEBI-registered intermediary (Broker, DP), you need not undergo the same process again when you approach another intermediary. As a business, we don’t give stock tips and have not authorised anyone to trade on behalf of others. If you find anyone claiming to be part of Univest Stock Broking Private Limited and offering such services, please send us an email at hello@unibrokers.in
    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.
    Update your email ID and mobile number with your stockbroker/depository participant and receive an OTP directly from the depository on your registered email ID and/or mobile number. Check your securities/mutual funds/bonds in the Consolidated Account Statement (CAS) issued by NSDL every month.
    Attention Investors: SEBI has established an Online Dispute Resolution Portal (ODR Portal) for resolving disputes in the Indian Securities Market. This circular streamlines the existing dispute resolution mechanism, offering online conciliation and arbitration, benefiting investors and listed companies https://www.sebi.gov.in/legal/circulars/jul-2023/online-resolution-of-disputes-in-the- indian-securities-market_74794.html. ODR portal for Investors - https://smartodr.in/login.
    Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.
    General
    arrow down